Tag: Prescription Drugs
Very Low LDL-C Levels Well Tolerated With Alirocumab
No increase in treatment-emergent adverse event rates, neurocognitive events with low levels LDL-C
Economic Benefit for Combo Statin/TG-Specific Tx in T2DM
Greatest cost reduction for statin/TG-specific-treated patients with TG level drop of ≥30 percent
Exenatide, Pioglitazone Effective for Poorly Controlled T2DM
Findings in patients with long-standing poorly controlled type 2 diabetes on metformin, sulfonylurea
Extending Rx Exclusivity Could Boost Study for Rare Diseases
Substantial compensation to many drug manufacturers, especially for top-selling products
Experimental Drug May Simplify Macular Degeneration Treatment
Animal tests showed fewer injections needed to treat age-related macular degeneration
Syphilis Risk May Be Higher in HIV Patients on Antiretrovirals
Medications may raise susceptibility to bacterium that causes the sexually transmitted disease
Modest Links for Systemic Medication Use, IOP in Glaucoma
Systemic β-blocker use linked to lower IOP; ACEI, ARB, statin, sulfonylurea linked to higher IOP
Cognitive Stress Reduces Levodopa Effect in Parkinson’s
Levodopa effect significantly smaller during cognitive co-activation than during rest
Tetracycline + Colchicine Effective in Hidradenitis Suppurativa
Combination treatment effective for disease control with signs of improvement at three months
β-Blockers Linked to Reduced Mortality in HFrEF, A-Fib
Reduction in all-cause mortality, but not hospitalization, regardless of pattern, burden of a-fib
